Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced on July 2 that on July 1, 2024, the company signed a structured deposit product agreement with Shanghai Pudong Development Bank, agreeing to subscribe to a total amount of RMB 200 million of structured deposit products with its own idle funds generated from daily operations.
复旦张江(01349.HK)：认购2亿元浦发银行结构性存款产品
Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co. Ltd. (01349.HK): subscribed 200 million yuan in Shanghai Pudong Development Bank's structured deposit products.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.